COMMUNIQUÉS West-GlobeNewswire

Sienna Announces September Dividend
13/09/2019
MARKHAM, Ontario, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Presentation och videointervju med Arcomas VD från Bolagsdagen den 12:e september.
13/09/2019
Arcomas VD Jesper Söderqvist presenterade Arcoma på Bolagsdagen på Erik Penser Bank den 12:e september 2019. Nu finns presentation och videointervju tillgänglig. Se presentationen här Se videointervjun här Om Arcoma [...]
The Eye Institute of Utah Among First in State to Offer PanOptix Trifocal IOL and the RxSight Light Adjustable Lens System
13/09/2019
Salt Lake City, Utah, Sept. 13, 2019 (GLOBE NEWSWIRE) -- The Eye Institute of Utah , a leader in comprehensive eye care and vision correction surgery, announces that their eye surgeons are among the first in Utah to [...]
Profound Medical Announces Pricing of Offerings
13/09/2019
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES TORONTO, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“ Profound ” or the “ Company ”) is pleased to [...]
Genmab Announces Positive Topline Results in Phase III Study of Daratumumab in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma
13/09/2019
Company Announcement Phase III CANDOR study of daratumumab in combination with carfilzomib and dexamethasone in relapsed or refractory multiple myeloma met the primary endpoint of improvement in progression free [...]
National Patient Survey Highlights Healthcare Challenges for the 1 in 4 Americans Living with Rheumatic Disease
13/09/2019
- 60% of respondents reported difficulty affording treatment -- Nearly half of respondents reported undergoing step therapy -- Two-thirds of respondents reported activity and lifestyle limitations due to their disease [...]
Intrommune Therapeutics Receives Support from Allergy & Asthma Network
13/09/2019
Tonya Winders, CEO, Allergy & Asthma Network Joins Intrommune Therapeutics Advisory Board New York, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , a New York-based biotechnology company developing the [...]
Detailed Results from the Phase III ASCLEPIOS I & II Studies of Ofatumumab in Patients with Relapsing Multiple Sclerosis Presented at ECTRIMS
13/09/2019
Company Announcement Details from the ASCLEPIOS I & II studies of subcutaneous ofatumumab (OMB157) versus teriflunomide in patients with relapsing multiple sclerosis (RMS) were presented at the 35th Congress of the [...]
Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program
13/09/2019
Hamilton, Bermuda, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology [...]
NimbleRx Officially Introduces Itself as First Delivery Service Designed for Independent and Local Pharmacies
13/09/2019
Nimble has already partnered with 600 pharmacies in the US and reached $150 million in annual GMV REDWOOD CITY, Calif., Sept. 13, 2019 (GLOBE NEWSWIRE) -- NimbleRx today formally unveiled itself as the first service [...]
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
13/09/2019
Both ASCLEPIOS I and II studies met their primary endpoints in patients with relapsing forms of MS (RMS)[1]; overall ofatumumab (OMB157), a subcutaneous, potent, fully-human antibody targeting CD20 positive B-cells, [...]
Weight Watchers International, Inc. to Change its Legal Name to WW International, Inc. Following Rebranding Last Year
13/09/2019
NEW YORK, Sept. 13, 2019 (GLOBE NEWSWIRE) -- WW (NASDAQ: WW), a global wellness company and the world’s leading commercial weight management program, today announced that it will be changing its legal name from Weight [...]
Philips Global Beauty Index reveals that women want personalized beauty solutions to meet their unique needs
13/09/2019
September 13, 2019 Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA), today released the findings of its fifth annual Philips Global Beauty Index, surveying over 12,000 women from 12 different countries [...]
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Bullous Pemphigoid
13/09/2019
NEW YORK and LONDON, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where [...]
Salarius Pharmaceuticals Announces Senior Leadership Changes
13/09/2019
Scott Jordan Appointed Chief Business Officer; Mark Rosenblum, Appointed Interim Chief Financial Officer HOUSTON, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage [...]
Akesis Galaxy™ SRS System Receives 510(k) Clearance
13/09/2019
CONCORD, Calif., Sept. 13, 2019 (GLOBE NEWSWIRE) -- The Akesis Galaxy™, a gamma stereotactic radiosurgery system (SRS) with continuous 360 o rotational technology, has received 510(k) clearance from the U.S. Food and [...]
Nexstim Plc Agrees on a New Loan Repayment Schedule with Kreos
13/09/2019
Company announcement, Helsinki, 13 September 2019 at 3.00 pm (EEST) Nexstim Plc Agrees on a New Loan Repayment Schedule with Kreos Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") – the company developing and [...]
VitalHub Announces Commencement of Second Phase of Licensing Agreement with The Salvation Army Toronto Grace Health Centre
13/09/2019
TORONTO, Sept. 13, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce that upon successful completion of the first phase of the project, it has entered phase two of the B Care EHR [...]
Todos Medical Signs Binding Term Sheet with HWH World for Network Marketing of Blood Tests for the Early Detection of Breast Cancer
13/09/2019
REHOVOT, Israel and SINGAPORE, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) , a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of [...]

Pages